Jiangsu Hengrui Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000014W7
CNY
57.31
2.95 (5.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
7,426.89
8,555.58
7,205.61
7,795.30
6,588.57
7,603.20
5,997.53
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,426.89
8,555.58
7,205.61
7,795.30
6,588.57
7,603.20
5,997.53
Raw Material Cost
1,080.48
1,147.04
1,169.40
1,105.25
1,050.13
1,018.93
1,031.32
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.69
0.74
10.92
2.25
0.00
3.31
0.00
Selling and Distribution Expenses
3,263.16
3,098.20
2,525.13
2,846.60
2,829.51
2,775.43
2,332.78
Other Expenses
171.67
161.39
144.22
196.00
143.93
174.66
115.24
Total Expenditure (Excl Depreciation)
6,061.02
5,859.86
5,147.63
5,914.11
5,318.97
5,544.26
4,516.51
Operating Profit (PBDIT) excl Other Income
1365.9
2695.7
2058
1881.2
1269.6
2058.8999999999996
1481
Other Income
104.26
244.48
127.96
199.51
147.43
268.86
72.06
Operating Profit (PBDIT)
1,389.26
3,099.21
2,355.38
2,176.45
1,576.00
2,498.99
1,707.58
Interest
0.69
0.74
10.92
2.25
0.00
3.31
0.00
Exceptional Items
-13.46
124.38
-13.11
99.10
1.99
0.20
7.34
Gross Profit (PBDT)
6,346.41
7,408.54
6,036.21
6,690.05
5,538.44
6,584.27
4,966.21
Depreciation
0.00
230.90
230.90
223.00
223.00
212.41
212.41
Profit Before Tax
1,375.11
2,991.95
2,100.45
2,050.30
1,354.99
2,283.47
1,502.51
Tax
55.51
397.10
199.16
362.29
146.94
188.45
135.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,301.06
2,576.05
1,874.06
1,716.95
1,187.83
2,062.82
1,368.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,301.06
2,576.05
1,874.06
1,716.95
1,187.83
2,062.82
1,368.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.50
2.18
2.39
3.71
0.37
-2.18
-1.44
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,305.56
2,578.23
1,876.44
1,720.66
1,188.20
2,060.64
1,367.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
59,504.25
58,464.83
46,987.06
45,519.86
43,767.91
42,622.24
41,873.50
Earnings per share (EPS)
0.2
0.4
0.3
0.27
0.19
0.32
0.22
Diluted Earnings per share
0.2
0.4
0.3
0.27
0.19
0.32
0.22
Operating Profit Margin (Excl OI)
17.3%
30.67%
27.71%
22.5%
18.3%
26.54%
23.73%
Gross Profit Margin
18.52%
37.67%
32.35%
29.16%
23.95%
32.83%
28.59%
PAT Margin
17.52%
30.11%
26.01%
22.03%
18.03%
27.13%
22.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -13.19% vs 18.74% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -49.36% vs 37.40% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -54.99% vs 28.16% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -93.58% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Jiangsu Hengrui Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
7,426.89
0
7,426.89
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,426.89
0
7,426.89
Raw Material Cost
1,080.48
0
1,080.48
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.69
0
0.69
Selling and Distribution Expenses
3,263.16
0
3,263.16
Other Expenses
171.67
0.00
171.67
Total Expenditure (Excl Depreciation)
6,061.02
0
6,061.02
Operating Profit (PBDIT) excl Other Income
1,365.87
0.00
1,365.87
Other Income
104.26
0
104.26
Operating Profit (PBDIT)
1,389.26
0
1,389.26
Interest
0.69
0
0.69
Exceptional Items
-13.46
0
-13.46
Gross Profit (PBDT)
6,346.41
0
6,346.41
Depreciation
0.00
0
0.00
Profit Before Tax
1,375.11
0
1,375.11
Tax
55.51
0
55.51
Provisions and contingencies
0
0
0.00
Profit After Tax
1,301.06
0
1,301.06
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,301.06
0
1,301.06
Share in Profit of Associates
0
0
0.00
Minority Interest
4.50
0
4.50
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,305.56
0
1,305.56
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
59,504.25
0
59,504.25
Earnings per share (EPS)
0.20
0
0.20
Diluted Earnings per share
0.20
0
0.20
Operating Profit Margin (Excl OI)
17.30%
0%
0.00
17.30%
Gross Profit Margin
18.52%
0%
0.00
18.52%
PAT Margin
17.52%
0%
0.00
17.52%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 742.69 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -13.19% vs 18.74% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 12.72% vs 12.72% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 130.56 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -49.36% vs 37.40% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 9.88% vs 2.38% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 128.50 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -54.99% vs 28.16% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -10.05% vs 3.67% in Sep 2024

Quarterly - Interest
Interest 0.07 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -93.58% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.30%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024